Search Results - "KOMPOLITI, K"

Parkinsonism and Parkinson’s disease by Kompoliti, K

Get full text

Cognitive therapies for psychogenic movement disorders by Kompoliti, K

Get full text

2.15.2 PSYCHOGENIC MOVEMENT DISORDERS (2) by Kompoliti, K

Get full text

Burden of cerebro-vascular disease in Cameroon by Doumbe, J, Mapoure, Y, Nyinyikua, T, Kompoliti, K, Shah, H, Cubo Delgado, E

Get full text

Neurological disease surveillance in Cameroon. A rural and urban-based in/outpatient population study by Doumbe, J, Mapoure, Y, Nyinyikua, T, Kompoliti, K, Shah, H, Cubo Delgado, E

Get full text

Pediatric neurological disease surveillance in Cameroon. An urban-based outpatient population study by Shah, H, Doumbe, J, Mapoure, Y.N, Nyinyikua, T, Kompoliti, K, Cubo Delgado, M.E

Get full text

Mortality and morbidity among hospitalized patients with neurological diseases in Cameroon by Kompoliti, K, Doumbe, J, Mapoure, Y, Nyinyikua, T, Shah, H, Cubo, E

Get full text

Prevalence of movement disorders in Cameroon. A rural and urban-based in/outpatient population study by Cubo, E, Doumbe, J, Nyinyikua, T, Mapoure, Y, Sha, H, Kompoliti, K

Get full text

2.15.1 PSYCHOGENIC MOVEMENT DISORDERS (1) by Hallett, M, Weiner, W.J, Kompoliti, K

Get full text

The importance of educational and psychological factors in Parkinson's disease quality of life by Cubo, E., Rojo, A., Ramos, S., Quintana, S., Gonzalez, M., Kompoliti, K., Aguilar, M.

“…Objective:  To define the factors correlated with quality of life (QoL) in patients with idiopathic Parkinson's disease (PD). Background:  PD has a substantial…”
Get full text

Copper by Kompoliti, K.

Get full text

Copper by Kompoliti, K.

Get full text

Copper by Kompoliti, K

Get full text

Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease by KOMPOLITI, K, WANG, Q. E, GOETZ, C. G, LEURGANS, S, RAMAN, R

“…To determine the effect of central dopaminergic stimulation with apomorphine on speech in PD. Most patients with PD have a speech disorder. Of those, 89% have…”
Get full text

Menstrual-related changes in motoric function in women with Parkinson's disease by KOMPOLITI, K, CORNELLA, C. L, JAGLIN, J. A, LEURGANS, S, RAMAN, R, GOETZ, C. G

“…Questionnaire studies have found that parkinsonism worsens in women during the premenstrual period, when estrogen and progesterone levels are presumably at…”
Get full text

Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome by KOMPOLITI, K, GOETZ, C. G, LEURGANS, S, RAMAN, R, COMELLA, C. L

Get full text

Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics by KOMPOLITI, K, ADLER, C. H, YONES, L. C, TAN, E, CARVEY, P, GOETZ, C. G, RAMAN, R, PINCUS, J. H, LEIBOWITZ, M. T, FERRY, J. J, BLASUCCI, L, CAVINESS, J. N, LEURGANS, S, CHASE, W. M

Get full text

Neuropharmacology in the elderly by Kompoliti, K, Goetz, C G

“…Psychotropic medications present special problems in the elderly because of altered pharmacokinetics and pharmacodynamics. Aging is associated with changes in…”
Get more information

Nurr1 in Parkinson's disease and related disorders by Chu, Yaping, Le, Weidong, Kompoliti, Katie, Jankovic, Joseph, Mufson, Elliott J., Kordower, Jeffrey H.

“…In mammals, the transcription factor Nurr1 is expressed early in development and continues to be detectable throughout the organism's lifetime. Nurr1 is…”
Get full text

Rating scales and quantitative assessment of tics by Goetz, C G, Kompoliti, K

Get more information